[1] Camfield CS, Striano P, Camfield PR. Epidemiology of juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2013, 28(Suppl 1): S15-S17. [2] Genton P, Gelisse P. The history of juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2013, 28(Suppl 1): S2-S7. [3] Wight JE, Nguyen VH, Medina MT, et al. Chromosome loci vary by juvenile myoclonic epilepsy subsyndromes: linkage and haplotype analysis applied to epilepsy and EEG 3.5-6.0 Hz polyspike waves [J]. Mol Genet Genomic Med, 2016, 4(2): 197-210. [4] Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study [J]. Neurology, 2009, 73(13): 1041-1045. [5] Wolf P, Yacubian EM, Avanzini G, et al. Juvenile myoclonic epilepsy: a system disorder of the brain [J]. Epilepsy Res, 2015, 114: 2-12. [6] Piazzini A, Turner K, Vignoli A, et al. Frontal cognitive dysfunction in juvenile myoclonic epilepsy [J]. Epilepsia, 2008, 49(4): 657-662. [7] Giorgi FS, Guida M, Caciagli L, et al. Social cognition in juvenile myoclonic epilepsy [J]. Epilepsy Res, 2016, 128: 61-67. [8] Schmitz B, Yacubian EM, Feucht M, et al. Neuropsychology and behavior in juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2013, 28(Suppl 1): S72-73. [9] Walsh J, Thomas RH, Church C, et al. Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2014, 35: 72-77. [10] de Carvalho KC, Uchida CGP, Guaranha MSB, et al. Cognitive performance in juvenile myoclonic epilepsy patients with specific endophenotypes [J]. Seizure, 2016, 40: 33-41. [11] Moschetta S, Valente KD. Impulsivity and seizure frequency, but not cognitive deficits, impact social adjustment in patients with juvenile myoclonic epilepsy [J]. Epilepsia, 2013, 54(5): 866-870. [12] Sarkis RA, Pietras AC, Cheung A, et al. Neuropsychological and psychiatric outcomes in poorly controlled idiopathic generalized epilepsy [J]. Epilepsy Behav, 2013, 28(3): 370-373. [13] Loughman A, Bowden SC, D'Souza WJ. A comprehensive assessment of cognitive function in the common genetic generalized epilepsy syndromes [J]. Eur J Neurol, 2017, 24(3): 453-460. [14] Aldenkamp AP, Weber B, Overweg-Plandsoen WC, et al. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement [J]. J Child Neurol, 2005, 20(3): 175-180. [15] Lesser RP, Luders H, Wyllie E, et al. Mental deterioration in epilepsy [J]. Epilepsia, 1986, 27(Suppl 2): S105-S123. [16] Serafini A, Rubboli G, Gigli GL, et al. Neurophysiology of juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2013, 28(Suppl 1): S30-S39. [17] Horton DK, Hynan LS, Lacritz LH, et al. An abbreviated Montreal Cognitive Assessment (MoCA) for dementia screening [J]. Clin Neuropsychol, 2015, 29(4): 413-425. [18] Kalinin VV, Nazmetdinova DM, Basamygin AV. Handedness, cognitive processing and intelligence in patients with epilepsy [J]. J Epileptology, 2014, 22(1): 5-10. [19] Thomas RH, Walsh J, Church C, et al. A comprehensive neuropsychological description of cognition in drug-refractory juvenile myoclonic epilepsy [J]. Epilepsy Behav, 2014, 36: 124-129. [20] Miragall M, Banos RM, Cebolla A, et al. Working alliance inventory applied to virtual and augmented reality (WAI-VAR): psychometrics and therapeutic outcomes [J]. Front Psychol, 2015, 6: 1531. [21] Munger Clary HM. Anxiety and epilepsy: what neurologists and epileptologists should know [J]. Curr Neurol Neurosci Rep, 2014, 14(5): 445. [22] Ruis C, van den Berg E, van Stralen HE, et al. Symptom Checklist 90-Revised in neurological outpatients [J]. J Clin Exp Neuropsychol, 2014, 36(2): 170-177. [23] Javed A, Cohen B, Detyniecki K, et al. Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up [J]. Seizure, 2015, 29: 34-40. [24] Ramirez-García T, Serrano-Castro PJ, Alonso-Morillejo E, et al. Cognitive profile of zonisamide and valproic acid in the treatment of idiopathic generalized epilepsy: a comparative observational study [J]. Neurol Ther, 2016, 5(1): 59-68. [25] Inoyama K, Meador KJ. Cognitive outcomes of prenatal antiepileptic drug exposure [J]. Epilepsy Res, 2015, 114: 89-97. [26] Haghighi M, Bajoghli H, Bigdelou G, et al. Assessment of cognitive impairments and seizure characteristics in electroconvulsive therapy with and without sodium valproate in manic patients [J]. Neuropsychobiology, 2013, 67(1): 14-24. |